| Authors | Pier Luigi Zinzani, Lionel Karlin, John Radford, Dolores Caballero, Paul Fields, Martine E D Chamuleau, Francesco d'Amore, Corinne Haioun, Catherine Thieblemont, Eva González-Barca, Carlos Grande García, Peter W Johnson, Gustaaf W van Imhoff, Thomas Ng, Karen Dwyer, Franck Morschhauser |
| Journal | Haematologica
(Haematologica)
Vol. 101
Issue 10
Pg. e407-e410
(10 2016)
ISSN: 1592-8721 [Electronic] Italy |
| PMID | 27418646
(Publication Type: Clinical Trial, Phase II, Letter, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
- CCR4 protein, human
- Receptors, CCR4
- mogamulizumab
|
| Topics |
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal
(administration & dosage)
- Antibodies, Monoclonal, Humanized
(administration & dosage)
- Antineoplastic Agents
(administration & dosage)
- Europe
(epidemiology)
- Female
- Humans
- Infusions, Intravenous
- Lymphoma, T-Cell, Peripheral
(diagnosis, drug therapy, mortality)
- Male
- Middle Aged
- Neoplasm Recurrence, Local
(diagnosis, drug therapy, mortality)
- Receptors, CCR4
(antagonists & inhibitors)
- Survival Rate
(trends)
- Young Adult
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|
